Key result
Continuous remote patient monitoring did not significantly reduce 30-day readmissions compared to matched controls (P=0.138), though no readmissions were due to heart failure.
Why the study?
The effect of continuous remote patient monitoring on reducing 30-day readmissions in heart failure patients was evaluated due to limited evidence.
Does a continuous remote patient monitoring program reduce 30-day readmissions in post-discharge heart failure patients?
Observational
No
Does a continuous remote patient monitoring program reduce 30-day readmissions in post-discharge heart failure patients?
Answers are grounded in this paper and cite their sources.
Continuous remote patient monitoring integrated into clinical workflows is feasible, though its effectiveness in significantly reducing 30-day readmissions requires validation in larger, randomized trials.
OBJECTIVES: The objective of this study is to evaluate the effect of a continuous remote patient monitoring (CRPM) program on reducing 30-day readmissions in a case-versus-retrospective-propensity-matched-control study of heart failure (HF) patients. Abstract: METHODS: The study was conducted at Endeavor Health (formerly known as NorthShore University HealthSystem), Evanston, IL, in three post-soft launch phases: Phase IIa, IIb, and Phase III. HF patients were monitored for 30 days postdischarge with wearable biosensors to collect continuous ambulatory physiological data and a study phone for capturing patient-reported outcomes via daily surveys. Sensor data were analyzed by rules-based and machine learning algorithms to alert on physiologic perturbation. Platform alerts and survey data were monitored by home health nurses (HHNs) who assessed patients and, following a structured escalation pathway, referred them to HF advanced practice providers (APPs) or physicians for further management. Abstract: = 0.138). All-cause readmissions occurred, but none were due to HF in phases IIa, IIb, and III. Abstract: CONCLUSION: Integrating CRPM directly into clinical workflows is feasible but challenging. Further research with larger patient cohorts and an adequately powered randomized trial is required to robustly evaluate the role of CRPM, machine learning algorithms, and cascading workflows in reducing 30-day readmissions.
No takes yet. Share an insight, caveat, or question.
Sultan et al. (2026) conducted an observational in Heart failure. Continuous remote patient monitoring (CRPM) program vs. Retrospective propensity-matched control was evaluated on 30-day readmissions (p=0.138). Continuous remote patient monitoring did not significantly reduce 30-day readmissions compared to matched controls (P=0.138), though no readmissions were due to heart failure.
Synapse has enriched 10 related papers. Consider them for comparative context: